• 410 Medical

  Participated · Equity · Jul 2026

  410 Medical develops advanced resuscitation technologies centered on its lead product, the LifeFlow infuser, which received FDA clearance in 2016. LifeFlow is used by more than 500 hospitals and EMS agencies and has been used to treat nearly 80,000 patients experiencing conditions like sepsis and hemorrhagic shock. The company was founded in 2013 and is based in North Carolina. In July 2026 410 Medical raised $12 million in growth financing led by Orlando Health Ventures to scale commercial operations and accelerate LifeFlow adoption. The company is also investing in a next-generation LifeFlow device planned for launch in 2027. The financing was supported by a syndicate of hospital and healthcare investors, reflecting continued commercial momentum.

• Venteur

  Participated · Series A · Apr 2025

  Venteur provides a personalized health technology platform that helps employers offer employees tailored health benefits and full control over their choices via Individual Coverage Health Reimbursement Arrangements (ICHRA). The platform serves a range of companies, from small teams to businesses with over 5,000 employees. Venteur reports having served 30,000 employees across 600 businesses. The company is led by Stacy and Tim Edgar and is based in San Francisco, CA. Venteur plans to use its new funding to accelerate product innovation, expand into new markets, and grow its team. The product emphasis is on giving employees high-quality, personalized options rather than one-size-fits-all employer plans. Venteur operates a health insurance platform and services that enable businesses to provide their employees with more choice and control over care. The company positions its product to prioritize employee well-being and financial success. Venteur combines platform capabilities with services to simplify employer-sponsored health benefits. The startup is based in Berkeley, California. It recently completed a seed financing, indicating early-stage funding activity. Venteur plans to use the new capital to expand operations and advance its product development efforts.

• CalmWave

  Participated · Equity · Nov 2024

  CalmWave offers the Quiet ICU via an Operations Platform that uses "Transparent AI" to make its reasoning and data visible and to recommend optimized alarm settings at the bedside. The platform ingests retrospective and real-time patient data — vital signs, interventions, and medication administration — to generate objective recommendations to reduce alarm fatigue. CalmWave reports a 58% reduction in non-actionable alarms in a retrospective analysis of a charter customer’s Cardiac Care unit. The company cites that 80–99% of ICU alarms are non-actionable and positions its product as a solution to improve clinician workload, patient outcomes, and staff retention. CalmWave operates as a SaaS platform and is expanding channel partnerships with GPOs such as Premier, Inc. and Partners Coop. The company will use new capital to accelerate market penetration and grow both new and existing channel partnerships. CalmWave provides a platform that ingests data from all devices a patient is connected to and delivers customizable views for clinicians, including individual patient views, ward summaries, and clustered patient alarms. Its platform produces “Operations Health Scores” that describe each nurse’s workload and well-being using factors such as alarm volume, response times, patient length of stay, and nurse-to-patient ratio. Key features include Smart Alarms that group alerts into incidents, Device Thresholds and Alarm Monitoring, Intelligent Patient Acuity scoring, Staff Orchestration to balance workloads and improve retention, Insights & Analytics for users across roles, and built-in Expert Services for assessment and implementation. The company is led by CEO and Founder Ophir Ronen. CalmWave says it will use the funds to recruit talent, advance new marketing initiatives, and create and launch innovative products. The product and roadmap are focused on reducing alarm burden, optimizing staffing, and improving patient outcomes through data-driven operational insights.

• Ferrum Health

  Participated · Series A · Sep 2024

  Ferrum Health provides a vendor-neutral, privately deployed enterprise AI platform that lets clinicians validate AI performance on local datasets and deploy models into existing workflows without PHI leaving the health system firewall. The platform's algorithm library covers oncology, women’s and men’s health, cardiovascular, neurology, orthopedics, and more. Led by CEO Pelu Tran, Ferrum is focused on improving patient outcomes by integrating validated AI into health-system workflows. The company reported that, as of 2024, its Enterprise AI Platform has analyzed more than 2,500,000 patient records. Ferrum intends to use the new funding to expand operations and accelerate development efforts. The article states the company is based in San Francisco, CA. Ferrum Health is a San Francisco-based healthcare AI company that has developed an Enterprise AI deployment platform to improve patient outcomes. Its platform offers AI Hubs that can run numerous applications across many service lines and integrate clinical imaging with administrative data. The system uses advanced machine learning algorithms to analyze medical data and provide clinicians with insights and recommendations. Ferrum has seen traction with major healthcare organizations such as Sutter Health and Carle Clinic adopting its technology. As of 2022, more than 750,000 patient records have been analyzed via the Ferrum Enterprise AI Platform. The company plans to use new funding to continue developing its Enterprise AI Platform and to expand its health system customer base to make intelligent healthcare more accessible. CEO Pelu Tran is named in the article as leading the company. Ferrum Health develops an enterprise AI patient safety platform for health systems that uses multiple computer vision algorithms to assess radiologic images for commonly missed pathologies and a proprietary natural language processing algorithm to correlate those findings with physician notes. The platform flags potentially missed findings for hospital quality officers and assists quality teams in the peer review of radiology studies. The company is led by co-founder and CEO Pelu Tran and is based in San Francisco, CA. Ferrum closed a $9M seed funding round to advance and refine its flagship platform. The company intends to use the proceeds to make key engineering hires and to grow its sales and marketing capabilities. No operating metrics (revenue/users) were disclosed in the article.

• Sharecare

  Led · Equity · Mar 2021

  Sharecare offers a suite of digital health and population-health products and has expanded its AI capabilities through acquisitions, notably Healthways' population health business and Doc.AI. The company licenses tools such as Doc.AI's Covid-19 evaluation tool and a mental-health chatbot to health plans, and works with plans on claims analytics and predicting medical events. CEO Jeff Arnold has described the company's aim as building a "Facebook for health" to drive vaccinations, mental-health support, care navigation and next-best-action guidance. Financially, reported revenue declined from $342 million in 2018 to $328 million in 2020, with a net loss of $61 million in 2020 (vs. $39M in 2019 and $55M in 2018). Sharecare projects revenue of $396 million in 2021 and $512 million in 2022, and says sales have picked up since the pandemic slowdown, adding clients such as Delta Air Lines. The company is pursuing a public listing via a SPAC merger while continuing to deepen strategic partnerships with payers like Anthem. Sharecare operates a comprehensive digital engagement and virtual care platform that delivers personalized health content, clinically validated tools, and provider solutions to individuals, employers, health plans, and providers. The platform includes data management tools and artificial intelligence capabilities to identify and close gaps in care and to enable providers to prescribe digital therapeutics and clinical programs through a secure, unified interface. Sharecare plans to co-develop consumer-facing offerings with health system partners and to integrate with electronic medical records to personalize care and improve outcomes. In Summer 2021 Sharecare’s virtual care platform was slated to roll out to Wellstar’s 24,000 team members. To support these strategic partnerships and custom development, Wellstar made a $10 million strategic investment in Sharecare. Sharecare also announced a definitive merger agreement with Falcon Capital Acquisition Corp. on February 12, 2021. Sharecare operates a comprehensive mobile health platform that provides personalized health profiles, evidence‑based programs, coaching tools and connections to health professionals and services. The platform serves individuals and also enables providers, employers and health plans to scale outcomes‑based health and wellness solutions across populations. Sharecare emphasizes data‑driven, frictionless technologies and clinically validated protocols to move users from assessment to action. The company highlights plans to expand its impact on individual and community well‑being, including initiatives focused on Georgia. Sharecare is based in Atlanta and Columbus, Georgia, and says partnerships like the one with Aflac will help accelerate its mission. Financially, the company reports it has raised more than $425 million in total capital since founding. Sharecare is an AI-powered digital health platform that leverages smartphones to give users access to personalized care and health management in a single place. Founded in 2010 and based in Atlanta, GA, the company applies artificial intelligence to aggregated behavioral data in real time to personalize recommendations and predict and influence positive outcomes. Its platform targets employees, health plan members, patients, caregivers and self-motivated individuals, driving daily engagement through a holistic focus on health. Sharecare aggregates a critical mass of behavioral data to deliver tailored recommendations and simplify health management for individuals. The company is led by president Justin Ferrero and was founded by Jeff Arnold and Dr. Mehmet Oz. The article does not disclose revenues or user metrics. Sharecare provides a comprehensive digital health platform that integrates personalization, interoperability and daily engagement to connect people with the healthcare system. The company has focused on population health solutions for large employers and health plans in addition to its provider and consumer offerings. Sharecare has integrated capabilities through building and acquisitions, including its 2016 acquisition of Healthways, and offers programs such as Dr. Ornish’s Program for Reversing Heart Disease. HMSA is rolling out Sharecare’s platform statewide in Hawaii, with ambassadors and employees already onboarded and deployment to all residents expected this summer. Sharecare plans to make the platform available to other health plans and employers and to add additional content, including the Blue Zones Project and Dr. Ornish program later this year. The company has said it is developing immersive health experiences that integrate virtual reality and 360-degree video to improve health engagement.

No current team members are available.